BMY vs TMP · P/E 17, rev $48.19B vs P/E 7.5, rev $79.3M
Bristol-Myers Squibb Company (BMY) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the BMY and TMP stock pages for the full models.
Not investment advice.